Covid-19: Sale of AstraZeneca vaccine to AU concluded - Health Minister Zweli Mkhize

accreditation
0:00
play article
Subscribers can listen to this article
Health Minister Zweli Mkhize.
Health Minister Zweli Mkhize.
Darren Stewart/Gallo Images
  • Health Minister Zweli Mkhize says the full purchase amount for the AstraZeneca vaccines was received Monday last week.
  • About a million doses of the AstraZeneca vaccine were sold to the African Union by South Africa. 
  • Mkhize says the first batch of vaccines that is being delivered will benefit nine member states.

Health Minister Zweli Mkhize says the sale of the one million doses of the AstraZeneca vaccine to the African Union (AU) has been concluded. 

In a statement on Sunday, Mkhize said the department had in the past weeks ensured that all member states identified by the AU vaccine acquisition team as recipients were compliant and had obtained regulatory approvals, permits and licenses to roll out the jabs in their countries. 

Mkhize said the full purchase amount was received by the department last Monday.

"The AU and South African teams then ensured that all logistical arrangements are in place for the shipment of the vaccines. The minister is pleased to announce that the first batch of vaccines that is being delivered will benefit nine member states. The balance will be collected this week to be delivered to five other countries," the department said. 

News24 previously reported that Mkhize said the sale of the vaccines would come cheap. 

Addressing the National Press Club earlier this month, Mkhize said local scientists were still working on research regarding the efficacy of the vaccine. 

He said the AU would buy the over a million vaccines at the same amount that was spent procuring them from the Serum Institute of India. 

ALSO READ | Covid-19 crisis: Stuttering SA left behind as Rwanda powers ahead in vaccination drive

The use of the doses was halted in South Africa after it was found to be not highly effective against the 501Y.V2 variant. 

In February, the department started rolling out the Johnson & Johnson vaccine to healthcare workers. 

News24 also reported that principal investigator of the AstraZeneca vaccine trials in South Africa, Professor Shabir Madhi, said he was "mortified" that government had "abandoned" the doses. 

The professor said there was still strategic use for the vaccines among high risk groups. 


Did you know you can comment on this article? Subscribe to News24 and add your voice to the conversation.
We live in a world where facts and fiction get blurred
In times of uncertainty you need journalism you can trust. For 14 free days, you can have access to a world of in-depth analyses, investigative journalism, top opinions and a range of features. Journalism strengthens democracy. Invest in the future today. Thereafter you will be billed R75 per month. You can cancel anytime and if you cancel within 14 days you won't be billed. 
Subscribe to News24
Rand - Dollar
15.73
-0.5%
Rand - Pound
19.78
-0.8%
Rand - Euro
16.80
+0.1%
Rand - Aus dollar
11.15
-0.2%
Rand - Yen
0.12
-0.1%
Gold
1,854.96
-0.6%
Silver
22.03
-0.4%
Palladium
2,014.35
+0.3%
Platinum
950.59
-0.6%
Brent Crude
113.56
+0.1%
Top 40
61,176
0.0%
All Share
67,585
-0.2%
Resource 10
74,448
+0.1%
Industrial 25
72,681
+1.3%
Financial 15
15,434
-2.4%
All JSE data delayed by at least 15 minutes Iress logo
Editorial feedback and complaints

Contact the public editor with feedback for our journalists, complaints, queries or suggestions about articles on News24.

LEARN MORE